Cochrane to oversee commercialization and business development for Viridis Chemical
Viridis Chemical, LLC (“Viridis Chemical”), a manufacturer of renewable chemicals, announces the hiring of Rick Cochrane as Senior Vice President Commercialization and Business Development. Mr. Cochrane will oversee all commercialization and business development opportunities for the Company.
Mr. Cochrane has had a long, successful career of strategy and business development in the chemicals and sustainable materials industries, including nine years with Waste Management, Inc., and four years with Continuus Materials, LLC.
Carl Rush, Co-Founder and CEO, stated, “We are excited to have Rick join the Viridis Chemical team. Rick is experienced in a variety of strategy and business growth functions that will be invaluable to our company, including at our existing plant in Columbus, NE, and as we evaluate new opportunities to expand our renewable chemical platform.”
Rick Cochrane, Senior Vice President of Operations, remarked, “The chemical industry and its customers continue to focus on sustainable and economically viable green products to supplement existing hydrocarbon-based processes. Viridis Chemical has taken the first step in providing a solution to participants in the space and I am thrilled to be part of the team. I look forward to helping accelerate the great progress Viridis Chemical has made to date on building a leading green chemical company.”
About Viridis Chemical
Headquartered in Houston, Texas, Viridis Chemical, LLC is a world-class manufacturer of renewable chemicals. We’re committed to the safe, environmentally sound, and economically viable conversion of bio-Ethanol into useful products previously derived from oil or natural gas. We provide value to our customers by offering a green, domestically sourced alternative to their existing supply chain. Viridis Chemical adds purpose to our suppliers and to the economy of Nebraska by further increasing the range of usefulness of local, agriculturally derived feedstock.
For more information, please visit www.viridischemical.com
